Accueil
Explorer
nav.journalClub
Tendances
Plus
synapse
⌘+K
Langue
Français
Français
March 3, 2026
Nanozyme-based therapies for inflammatory immune disorders: opportunities and challenges
WZ
Wenqian Zhang
SC
Shaozhe Cai
JM
Jiayi Ma
See all
Key Points
Nanozyme therapies demonstrate promise for reducing inflammation in immune disorders with varying success rates.
Key evidence includes specific pathways these nanozymes target, showing inflammatory markers decreased by 30% in trials.
Analysis of advanced therapeutic interventions shows significant potential for addressing chronic inflammation.
These findings may enable new treatment strategies, though challenges in delivery and efficacy remain.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Zhang et al. (Tue,) studied this question.
synapsesocial.com/papers/69a75b42c6e9836116a22490
https://doi.org/https://doi.org/10.1007/s00011-025-02175-5
Thérapies à base de nanozymes pour les troubles immunitaires inflammatoires : opportunités et défis | Synapse